Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-08

Clinical Trial Update: Transplantation of Anaerobic Cultured Human Intestinal Microbiota in Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update on transplantation of anaerobic cultured human intestinal microbiota for irritable bowel syndrome (IBS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transplantation of anaerobic cultured human intestinal microbiota

Snippet

Sponsor: Uppsala University | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: UNKNOWN